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RNA is critical in countless cellular processes, and researchers are constantly discovering new 
types and attributing them different roles. Consequently, a growing interest in efficient RNA 
analysis has arisen. However, RNA detection is complicated and generally requires the use of 
labels. Major efforts are being devoted to conceive new approaches for RNA analysis with no 
need of markers. Optical biosensing is a highly sensitive approach that circumvents many of 
conventional methods’ limitations. Lately, label-free applications with optical biosensors have 
been developed for short as well as for long RNAs. The low limits of detection at the pM level 
enabled by optical biosensors, together with a fast analysis, their reusability and the label-free 
scheme of operation, clearly highlight them among the most promising next-generation RNA 
screening platforms. This review covers the most relevant optical biosensor platforms and 
their potential for enabling sensitive and label-free RNA analysis. 
 








1. RNA, a key player in the biology of cells 
Gene expression is finely regulated in cells for the proper management of protein production 
and their contents in the right place at the correct time, guarantying the perfect equilibrium 
necessary for ensuring cell survival. Great number of macromolecules and processes are 
involved, making it more and more difficult to elucidate which mechanism leads the cell to 
choose one pathway or another. Recently, researchers have focused on the multiple and 
variable function of RNAs[1], which play critical and diverse roles in countless cellular 
processes. Current methodological advances, including bioinformatics, microarray-based, 
biochemical and deep-sequencing studies, are revealing new insights into the roles that the 
regulation of RNA has in generating organism complexity from a relatively small number of 
genes.   
Although they share the same nature, the RNA family is very diverse – in sequence and 
structure- having different and crucial roles in cell biology (see Table 1)[2-14]. Depending on 
whether they are involved in protein production or other regulatory functions, they have been 
classified into protein coding RNAs and non-coding RNAs (nc-RNAs)[15]. Protein coding RNAs 
are solely represented by the messenger RNA (mRNA), though constituting a large family of 
RNA molecules that convey the genetic information from the DNA, directly serving as 
templates for the protein translation. On the contrary, the ncRNA family covers RNAs of many 
different lengths (from ~20 to ~several kb) and properties, most of whose functions are 
unknown. Although many classifications have been proposed the most widely accepted is that 
based on their structural or house-keeping roles and their regulatory role (Table 1). At the 
same time, ncRNAs playing regulatory roles are sub-classified according to their length in short 
(~20-200 nt) and long nc-RNAs (200 nt up to several Kb). 
 
Until recently, ncRNAs were supposedly inert; but far from being of any usefulness, they have 
demonstrated to account for most of the cell’s genomic output[9, 16] and display a very wide 
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repertoire of biological functions such as cell cycle regulation, pluripotency, retrotransposon 
silencing, meiotic entry, telomere length, imprinting or dosage compensation. To execute their 
function, ncRNAs can either control the transcription or translation of proteins via a number of 
mechanisms including provision of the machinery for translation (i.e., rRNAs and tRNAs), 
mediating in the splicing process (e.g., intronic RNAs) remodeling the epigenome (i.e., DNA 
methylation and histone modification) [17, 18] or by interacting with other RNAs and proteins. 
For example, miRNAs in the cytoplasm can interact with the mRNA product and inhibit its 
translation process. At the transcriptional level, nc-RNAs such as ln-ncRNAs  can interact with 
the genomic DNA via formation of duplexes [13, 19-23] or triplexes [6, 9, 11]—an epigenetic 
pathway that has only recently been discovered [9, 11, 24], and recruit other protein regulator 
factors to alter gene expression. Importantly, these functions are not limited to the cell 
environment where the nc-RNA has been transcribed. Some non-coding RNAs can be exported 
out-of-cells via exosomes [25, 26] or  freely circulate into the bloodstream [27]. This enables 
these ncRNAs to target other cells from distant organs. Exportation of RNA from cells is 
paramount in the onset of many diseases (e.g., cancer); thus, researchers have endeavored to 
identify biomarkers in these pathways that can be exploited for early diagnosis and treatment 
[28]. 
 
Nonetheless, the remarkable plasticity of RNA can even surpass the coding/non-coding 
classification. Recent investigations [4] are showing that protein-coding and non-coding RNAs 
might not be mutually exclusive; some RNAs can function both as mRNAs and as functional 
ncRNAs, thereby RNA should be rather regarded as a multi-tasking molecule that can produce 
multiple products and that comprises a hidden stage of various levels of gene expression 
players and controllers. 
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Due to the increasingly recognized physiological importance of RNA in physiology and 
development, along with recent ground-breaking insights into its functions, RNA has been 
catapulted to the research forefront. RNA regulatory networks may determine most of our 
complex characteristics, which play a significant role in diseases and constitute an unexplored 
world of genetic variation both within and between species. 
 
2. Challenging aspects of RNA detection  
Regardless of the method employed for RNA analysis, there are intrinsic features on RNA 
molecules that deserve careful consideration for successfully designing a detection assay. 
These features can be summarized under the five “S’s” criteria, i.e., stability, sensitivity, 
specificity, size, and structure [29]: 
 
Stability: RNA is relatively unstable at room temperature, and it is extremely sensitive to the 
destructive action of ribonucleases and alterations in pH [30]. However, there are some 
exceptions, such as circulating RNAs in the bloodstream, which are stabilized and protected by 
other molecules and structures (e.g., exosomes).  
 
Sensitivity: Cellular concentrations for many RNA types are typically very low. This, together 
with the low stability of RNA, leads to the need of very sensitive methods for RNA detection. 
However, many conventional techniques does not provide that sensitivity [31] requiring 
microgram quantities of total RNA ―equivalent to over million cells―to achieve detection. 
This might become problematic when the sample comes from precious sources like biopsies or 
microdissections. The challenge of RNA detection goes forward when it is intended for 
capturing RNAs present in serum or plasma (i.e. circulating RNAs) which might exhibit 
extremely low concentration levels. In this regard, the method employed for extraction of 
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these RNAs also play a crucial role in the quality and quantity of RNA extracted and can directly 
impact the sensitivity of the method employed for detection. 
 
Specificity: RNA molecules of the same family (e.g., mRNA) often share physicochemical 
properties [32] and even share portions of sequence. For example, the different isoforms 
generated by the alternative splicing of a gene share one or more exonic sequences that might 
complicate the specific detection of one of them (i.e., detection without cross-talk from the 
other). The same problem arises with pre-microRNAs (pre-miRNAs) and its final miRNA 
product, since the miRNA sequence is already contained within the pre-miRNA one. Also close-
related RNA sequences, such as those from members of the same miRNA family might only 
differ in one or few nucleotides, making their accurate detection challenging. 
 
Size: RNA types vary greatly in length according to their function, they can go from 18 
nucleotides (nt) to several thousands. For example, non-coding RNAs such as microRNAs can 
be as short as 18 to 20 nt, whereas other RNAs such as mRNAs, rRNAs and lnRNAs are very 
long (> 200 nt). Size affects detection in many ways: for instance, short RNAs are difficult to 
detect, as they have the same length as the primers used in most detection methods, whereas 
long probes hybridize well but have poor sequence specificity. 
 
Structure: A hallmark of RNAs is that they tend to be very structured, especially as they 
increase in length. Unlike DNA, RNA has ribose within the nucleic acid backbone, which 
provides an extra oxygen atom that is free to promote further interactions between 
nucleotides. Pairing of local nucleotides generates secondary structures (e.g. hairpins and stem 
loops), while interactions among distantly located sequences generate tertiary structures [33]. 
The 3D-structure of an RNA molecule is essential to its biological function, but this inherent 
geometry can impair hybridization of RNA to a capturing probe [34]. 
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3. Methods for RNA analysis 
3.1 Conventional methods for RNA analysis 
Current methods for RNA analysis are mostly based on processive PCR-based technologies 
whereby amplified products of reverse-transcribed RNAs are analyzed. This approach affords 
semi-quantitative data on a limited number of expressed genes. For the simultaneous test of 
thousands of expressed genes (expression profiling), micro- and nano-arrays are more 
appropriate tools [35, 36]. Other conventional methods, such as Northern Blot or Ribonuclease 
Protection Assay (RPA) are also common, but achieving a high level of multiplexing is more 
challenging. 
 
Even the best of these RNA detection methods is limited by the 5 S’s above mentioned, 
requiring especial strategies to deal with them. For example, to overcome sensitivity, most of 
them incorporate some kind of sample amplification and/or signal amplification [37]. While 
sample amplification strategies amplify RNA samples prior to detection, either exponentially or 
linearly (i.e., using PCR or RNA/DNA polymerase-based methodologies), signal amplification 
strategies amplify the signal from labeled targets (e.g. using 3DNA dendrimers, quantum dots 
or branched DNA). Labeling is indeed a major requirement for most RNA detection methods 
since they are not only critical for sensitivity, but for increasing specificity. They become even 
more essential when using multiplexed approaches such as microarrays. Conversely, the 
labeling process makes detection slower, costlier and less reliable, since it is often difficult to 
precisely control the number of labels on each molecule across different experiments. 
Moreover, due to some of the “5 S’s” RNA intrinsic features, such as RNA size variation and 
2D/3D structure; it is complex to equally label all species of a particular RNA type in the sample 
regardless of specific sequence or structure. For example small RNAs labeling can be 
particularly complicated to perform in a reliable way, as their short size impedes direct 
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incorporation of labels by ligation or chemical modification [38]. When any label signal bias 
arises, quantitative analysis becomes challenging.   
 
In addition to the “5 S’s” issues, there are also many others affecting the reliability of RNA 
analysis. Template preparation and the dispensing of reagents might be subjected to a certain 
degree of variability and contamination when different operators prepare multiple templates, 
which can only be reduced using expensive robotized systems [35]. For example, the reliability 
of RNA detection via micro/nanoarrays has been questioned, as they are influenced by array 
production, RNA extraction, probe labeling, hybridization conditions and image analysis [39-
42]. 
 
As a consequence, standardization of RNA detection is non-trivial [30, 31, 37]. There is a real 
need for the development of novel detection methods tailored to deal with problematic 
intrinsic features of RNA, namely, easy-to-use, highly-sensitive diagnostic devices that provide 
quantitative data on RNAs from crude biological extracts, and that do not require reverse-
transcription, amplification or labeling. 
 
3.2 Biosensors as ideal platforms for label-free RNA analysis 
The ideal screening platform for RNA would be, above all, label-free, enabling the access to the 
entire target RNA population in the sample; consequently, the results would be more 
reproducible and reliable, not depending on the number of labeled molecules.  
 
Current label-free assay biosensor technologies provide a rapid and often real-time analysis, 
affording direct measurement of the affinity, kinetics and thermodynamics of biomolecular 
interactions in vitro—information that is difficult, if not impossible, to collect by other 
 8 
methods. These technologies can provide the clearest—and most quantitative—biochemical 
characterization of molecular interactions available today [43]. 
 
Albeit obviating the use of labels is crucial for improving current methods for RNA analysis, 
several other features are desired, such as greater specificity, sensitivity and reproducibility; 
amenability to the full range of RNA lengths; and the ability to detect structured targets. Label-
free based biosensors are emerging as ideal tools for the next-generation of RNA detection 
methods since they can offer rapid, label-free detection of biomolecules of any type with 
excellent specificity, sensitivity and reproducibility [43-48]. In addition, recent advances in 
nanotechnology have triggered the development of novel nanobiosensors, which are gradually 
progressing from the lab to the clinic. Future lab-on-a-chip devices incorporating an array of 
nanobiosensors could be employed to rapidly and simultaneously screen various analytes at 
low cost and using minimum volumes of physiological sample [49-52]. 
 
The success achieved with biosensors derives from their basic composition: a biosensor 
contain a biological component, the receptor, which recognizes a target molecule in a specific 
way; and a signal-generating component, the transducer, which detects the resulting 
biomolecular interaction and converts this interaction into a measurable signal [53] (see Fig. 
1). The presence and concentration of biological molecules in a given medium are measured by 
translating the biochemical interaction occurring at the sensing surface into a quantitative 
physical signal. This implies that the receptor(s) used must be previously immobilized onto the 
transducer surface and be highly specific for the target analyte(s). Biofunctionalization of the 
sensor surface is a critical step for ensuring high specificity and sensitivity [54]. Indeed, 
although sensitivity is highly dependent on the transducer method, astonishing results can be 
obtained when biofunctionalization is finely optimized [55, 56]. 
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The working principle of a biosensor depends on the type of transducer used, which is selected 
according to the analysis required. The most employed are electrochemical transducers and 
optical transducers [57-59]. Electrochemical biosensors offer excellent sensitivity and are 
highly amenable to miniaturization and to multiplexing detection; however they usually 
demand labeling and/or amplification strategies to generate a sensitive reaction, which in turn 
might complicate the detection scheme [60]. Optical sensors afford label-free detection with 
high sensitivity; they can be also miniaturized and multiplexed although the instrumentation 
can be complex [58]. As optical methods are the most feasible for label-free detection this 
review will focus only on recent advances in RNA detection achieved by optical biosensors.  
 
3.2.2 Optical biosensor platforms 
Optical biosensors based on the detection of changes in the refractive index (RI) [61] in the 
vicinity of the sensor surface are the most employed for label-free analysis. In these biosensors 
the binding of the analyte to its specific bioreceptor produces a local change in the refractive 
index at the sensing surface that is evaluated by the transducer. Refractive index changes are 
probed by the evanescent electromagnetic field that is generated in either guided or resonant 
optical modes traveling in the transducer. An evanescent wave is a near-field standing wave 
whose intensity exhibits exponential decay with distance from the boundary at which the 
wave is formed; it can range from a few tens to a few hundreds of nanometers, exhibiting the 
highest intensity at the sensor surface. As the optical detection of the local changes in 
refractive index is confined to the sensing surface—where the target is captured by the 
receptor—these methods are insensitive to the presence of unbound analyte or to other 
interfering molecules in the bulk solution. Moreover, detection is related to the sample 
concentration or surface density, instead of to the total sample mass, since the detection 
signal does not scale down with the sample volume. This characteristic is particularly attractive 
when a small detection volume is involved, and it is advantageous over other labeled-based 
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methods, whose signal usually depends on the total number of analytes in the detection 
volume.  
 
The main types of RI-based biosensors (extensively reviewed in refs [61-66]) are:  
(i) Surface Plasmon Resonance (SPR) biosensors (see Fig. 2A): They are based on the 
generation of a surface plasmon wave, a charge density oscillation that occurs at the 
interface of a metal (the transducer surface, typically gold, onto which the bioreceptors 
are immobilized) and a dielectric [67]. There are several configurations for SPR sensors, 
the most widespread of which is the Krestschmann configuration. SPR is a well-known 
technology and is commercialized by several companies worldwide. SPR is a very sensitive 
biosensor technique, but is challenging for multiplexing. There are other plasmonic 
configurations with better multiplexing capabilities, such as Localized Surface Plasmon 
Resonance (LSPR) sensors (which use metal nanostructures) and Surface Plasmon 
Resonance imaging (SPRi) sensors (based on the spectroscopy analysis of the whole 
sensor surface where different receptors have been spotted in separated dots; Figure 2B). 
Other technique, Surface Enhanced Raman Scattering (SERS) (excited by localized surface 
plasmon resonances) can afford a high level of sensitivity and it is particularly interesting 
for multiplexing, but it is more complex to handle and integrate. In general, SPR-based 
biosensors can reach detection limits in the nM-pM range, and this limit can be even 
improved by using non-labeling target amplification strategies (e.g., use of secondary 
antibodies, enzymatic reactions or nanoparticles).  
(ii) Resonant waveguide based biosensors: In these sensors the incident light is generally 
coupled in a waveguide at a specific resonant angle, and the guided mode shows a strong 
evanescent field [62]. Consequently, the resonant angle is sensitive to the RI change near 
the waveguide surface. Examples include resonant mirrors [68, 69] (RM) and metal-clad 
waveguides (MCWG) [70]. 
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(iii) Integrated interferometer-based biosensors: They are based on interferometric 
evaluation of the changes in the wave-vector of a guided mode as a consequence of the 
biomolecular recognition event. The most relevant examples are the Mach-Zehnder [71] 
and the Young interferometers [72]. They are extremely sensitive—orders of magnitude 
higher than SPR– but their integration and multiplexing are technologically 
complex.  Recently, an innovative type of interferometer-based biosensor, the bimodal 
waveguide (BMW) sensor, has been introduced [52]. It offers the high sensitivity of 
interferometric biosensors, as well as greater amenability to integration, miniaturization 
and multiplexing (see Fig. 2C). 
(iv) Micro-ring resonators based biosensors (see Fig. 2D): they constitute an emerging sensing 
technology where ring-shaped waveguide structures (micro-rings) are optically coupled to 
one or more linear waveguides, patterned on a planar surface. The light propagates inside 
the micro-ring in the form of whispering gallery modes (WGMs) which generate an 
evanescent field at the resonator surface. The effective light-analyte interaction length of 
a ring resonator sensor is determined by the number of revolutions of the propagating 
light supported by the resonator [73]. 
(v) Optical fiber-based biosensors: Like planar waveguide biosensors, optical fibers exhibit an 
evanescent field along their structure that penetrates into the external medium, where 
the biosensor reaction occurs. Interesting types include nanofibers, Bragg fibers and 
Fabry-Perot based fibers  [74]. 
(vi) Photonic crystal (PC)-based biosensors (see Fig. 2E): photonic crystals have a periodic 
dielectric structure with a periodicity on the order of the light wavelength that forms a 
photonic bandgap. When a photonic “defect” is introduced within the bandgap, the light 
resonant with the defect mode can propagate in the PC. Since the spectral position of the 
defect mode is highly sensitive to the change in the local environment around the defect, 
it can be used as the sensing transduction of the binding of the analyte molecules to the 
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defect. Photonic crystal-based biosensors have the advantage of strong light confinement, 
provided by the photonic cavity, and high flexibility for adjusting the defect mode 
wavelength across the photonic bandgap [75]. 
 
4. Current applications for detection of RNA using optical biosensors  
To date, most of the optical biosensor applications for RNA analysis have chiefly focused on 
miRNAs, m-RNAs, r-RNA and recently, on RNAs potentially interacting with the genomic DNA 
via formation of triplexes. Despite the extensive literature on many different biosensor 
schemes employed to detect nucleic acids, most are mainly devoted to DNA oligonucleotides 
[76]. In principle, given the similarities between DNA and RNA, the results obtained for DNA 
oligonucleotides could be considered valid for the homologous RNA sequence. However, 
extraction is really a challenging aspect of RNA determination, which can strongly influence the 
analytical performances of biosensing tools when addressing detection directly from real 
biological samples. Therefore, since the RNA-detection capability of these schemes has not 
been demonstrated with real RNA samples, applications using DNA oligos have not been 
considered in this review.  
 
There are also examples of indirect RNA detection, whereby the RNA sample is first converted 
into cDNA by methods such as RT-PCR. Given that the conversion step complicates the 
detection and limits the biosensing technology from offering any unique advantage over 
reverse-transcribed based conventional methods, these applications have not been considered 
either. This review has therefore strictly focused on biosensor applications for directly 
detecting different types of RNA (including synthetic RNA) in biological samples without any 
reverse-transcribed amplification. A summary of the main outcomes and analytical 
performances of each method in the detection of the different RNA types is depicted in Table 
2. 
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4.1 Detection of small RNAs 
Several types of optical biosensors have been employed to detect small RNAs (mostly 
in the range of 20 nt) such as miRNAs. Surface Plasmon Resonance biosensor and its 
microarray format homolog, SPRi, have shown to be incredibly versatile and effective for direct 
sensing of miRNA. However, the short length of small RNAs translates to a small mass to be 
detected, which reduces their capability to achieve high sensitive detection (sensitivity is 
typically in the nM range). To enhance sensitivity researchers have employed a variety of non-
target labeling amplification strategies, which enable detection limits at the pM or even fM 
levels. The disadvantage of these strategies is that the addition of one or more post-detection 
steps requires longer measuring times. Typically, standard SPR detection takes less than few 
minutes; however, addition of an amplification strategy can extend the read-out under 1 h, 
which is still reasonable. For example, Sipova et al. [77] achieved rapid, label-free detection of 
miRNA-122 from mouse liver tissue at 0.2 nM, using a novel, high-performance portable SPR 
sensor. But they managed to lower their previous detection limit by two orders of 
magnitude—down to a reported value of 2 pM—by performing an amplification step in which 
the captured miRNA is subsequently recognized by an antibody that exhibits affinity to the 
RNA*DNA hybrids. Nonetheless, the linear range of evaluation only extends to miRNA 
concentrations up to 10 nM and 0.1 nM for the hybridization and antibody-recognition steps, 
respectively (Fig. 3A). The sensitivity for evaluating RNA concentrations under these values is 
limited and, probably, unreliable. Despite the additional antibody step, the total time for 
miRNA detection was only 35 min. A similar strategy was developed by Nasheri et al. [78]. They 
directly detected synthetic miR-122 using a SPRi biosensor achieving a detection limit of 40 
nM. After hybridization, the signal was amplified using the protein p19, which has affinity 
towards the hybrid RNA/RNA duplex. Although this strategy is interesting for demonstrating 
the utility of p19 for the recognition of miRNA-bound probes, this approach does not appear to 
be as effective as the antibody-recognition one: Nasheri et al. were only able to lower their 
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detection limit by one order of magnitude, whereas Sipova et al. achieved two orders of 
magnitude. However, the worse detection limit of the former could also be due to the 
technique itself, as SPRi is less sensitive than standard SPR.  
Detection can also be largely improved through the use of more effective strategies for 
amplification and biofunctionalization. For example, Fang et al. analyzed three types of 
synthetic miRNAs (miR-16, miR-23b, and miR-122b) by SPRi achieving an incredible detection 
limit of only 5 attomoles (10 fM) [56]. They optimized the biofunctionalization by (i) using 
locked nucleic acid (LNA) probes, which have demonstrated to increase both the sensitivity 
and the specificity of hybridization [79] and (ii) subsequently recirculating the miRNA target 
solution over the LNA-derivatized sensing surface for 4 h. Although this is a long assay period, 
it enabled better saturation of the receptors for a given miRNA concentration, thus obviating 
the use of higher concentrations. Regardless, the cornerstone of their success was probably 
the impressive degree of amplification that they obtained using a two-step approach involving 
enzymatic polyadenylation extension of captured miRNAs followed by recognition of the 
generated polyadenylated tails by nanoparticles coupled to polythymidine oligonucleotides 
(see Fig. 3B). The real-time capability of this sensor enabled monitoring the entire procedure in 
real-time, including the polyadenylation reaction, in which the incorporation of each adenine 
was observed. The use of total RNA sample extracted from mouse liver tissue as a source for 
miRNA determination instead of synthetic miRNAs did not affect significantly the analytical 
performance of this method, which still could demonstrate detection of these miRNAs at 
femtomolar concentrations. Moreover, they tested the same amplification strategy on a novel 
optical biosensor technique based on Nanoparticle-Enhanced Diffraction Gratings (NEDG). In 
this sensor the optical properties of surface plasmons generated on gold gratings are coupled 
to the optical properties of adsorbed gold nanoparticles [80]. Using this sensor, synthetic miR-
122b targets were detected at a concentration of 50 pM, which was higher than when using 
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the SPRi sensor. However, the NEDG sensor could be improved by the ability to tune the 
plasmon excitation wavelength in the gratings using different types of nanoparticles. 
Zhou et al. [81] devised another interesting amplification strategy for SPRi, for the 
analysis of three synthetic miRNA mimics. They employed DNA-modified silica nanoparticles 
complementary to the miRNA target for capturing. The target was then fixed to the 
nanoparticle-DNA sequence by using a T4-ligase enzymatic reaction. Finally, the read-out of 
the nanoparticle-target pair was done by SPRi using receptor probes arrayed on the sensor 
surface that were also complementary to the target RNA sequence. The silica-nanoparticle 
step plays a double role towards enhancing target detection: firstly, it enables purification and 
concentration of the target, as they can be centrifuged, separated, washed and reconstituted 
in a smaller microliter volume format; and secondly, it enhances the target recognition signal, 
as it amplifies the mass loading at the sensor surface. The final result is a biosensor method 
able to detect multiple ssRNA sequences at concentrations as low as 100 fM. Recently, Joshi et 
al. [82] developed a technology based on solid-state localized surface plasmon resonance 
(LSPR) consisting of highly sensitive nanostructures (gold nanoprisms). They achieved the 
direct detection of miRNAs 21 and 10b at a LoD 23-35 fM in plasma extracted total RNA. 
Detection of the same miRNAs from raw plasma samples without performing the RNA 
extraction step showed that miRNA concentration in extracted samples was at least 2-fold 
lower than in the pure plasma samples. This outcome puts in evidence the large impact of the 
methodology employed for RNA extraction in the accuracy of detection since it can cause 
significant loss of miRNAs during the RNA extraction process. The large sensitivity of LSPR, 
which enables performing detection without the need for sample purification and pre- or post- 
amplification steps place this type of biosensing technology at the forefront of miRNAs 
detection technologies. 
Microring resonators based biosensors demonstrated to be as sensitive as SPR for 
detecting the changes in refractive index that accompany the binding of a miRNA target. Qavi 
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et al. [83] employed arrays of silicon microring resonators to analyze four miRNAs from a 
clinically-relevant sample of a cell-line model of glioblastoma, with minimal sample 
preparation (see Fig. 3C). They reached a detection limit of 150 fmol (~2 nM) without any 
amplification, a similar value to that obtained by SPR; however, they achieved a wider linear 
dynamic range of more than two orders of magnitude. To achieve this wide range, rather than 
utilize the absolute wavelength shift, which saturates as miRNAs hybridize to all of the 
available ssDNA capture probes, they determined the rate at which the resonance peak 
changes immediately after target introduction, and they used the initial slope response for 
quantification. The advantages of this approach were the generation of a linear calibration and 
a decrease in the total assay time (∼10 min).  
Driskell et al. [84] employed Surface-Enhanced Raman Spectroscopy (SERS) to detect 
five different synthetic miRNAs at M level (but it only requires 1L of RNA sample) in very 
short acquisition time (only 10 s). Interestingly, they identified single nucleotide 
polymorphisms that enable discrimination among eight members of the let-7 miRNA family. 
SERS is a promising method for miRNA detection that enables label-free detection of 
multiplexed miRNA. However, due to the subtle differences in peak intensity as a function of 
distinct—but related—sequence composition, the identification of specific sequences requires 
extensive multivariate analysis. A novel integrated optical biosensor based on a slot waveguide 
Mach-Zehnder interferometer (MZI) configuration was also developed for multiplex miRNA 
detection by Liu et al.[85]. It allowed a rapid and accurate detection of two types of miRNAs 
(miR-21 and let-7a) in human urine samples in a single reaction down to 1fM level of 
sensitivity. Moreover, this biosensing platform also demonstrated the ability to identify the 
single nucleotide polymorphism of the let-7 family of miRNAs. This large sensitivity and 
specificity alongside its capability for integration put this biosensor a step forward for the 
development of a point-of-care (POC) test for disease-associated miRNAs.  
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While all these methods perform well in terms of specificity and sensitivity in compare 
to conventional methods, perhaps the main challenge yet to be addressed by optical sensors is 
to demonstrate simultaneous detection of hundreds or thousands of miRNAs, which is a 
requirement for some biological applications. Many optical platforms have the potential for 
massive parallel screening (e.g., SPRi), however, most demonstrations currently available are 
limited to just few RNA candidates. Therefore, further work is required to fully demonstrate 
the applicability of optical sensors for miRNA analysis. 
4.2 Detection of long RNAs 
4.2.1. Messenger RNA (mRNA). Messenger RNA (mRNA) analyses are required for 
understanding certain biological mechanisms, for example, to determine whether changes in 
mRNA levels correlate to the translation of a given protein and to pinpoint the cell types that 
exhibit said changes, which in turn might be related to the onset of many diseases. Albeit the 
number of copies of mRNA in a cell type varies drastically depending on the mRNA type, the 
number of copies of any given mRNA in a cell extract is usually very low. Thus, mRNA detection 
requires high sensitivity. Although challenging, the advantage of mRNA biosensing relative to 
short ones, such as miRNAs, is that they have larger mass and generate larger refractive index 
changes. As a result, detection of cellular levels of mRNAs does not always require post-
capture amplification strategies. Conversely, detection of mRNA suffers from certain 
drawbacks: for instance, since they are longer they exhibit extensive secondary structures that, 
together with their large size, might increase the probability of inadequate orientation and 
poor accessibility. Also, diffusion of mRNA is considerably slower than that of smaller RNA 
molecules, which translates into longer assay times for comparable sensor responses [86, 87]. 
Another problem is specificity: discrimination among the huge variety of mRNAs within a given 
cell is not trivial; especially among gene-related isoforms (these are generated by transcription 
of the same gene during alternative splicing and can share one or more exons).  
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Taken together, the aforementioned difficulties might explain why the literature 
contains only a few examples of mRNA detection by optical biosensors. One such example is 
the work reported by Kindt et al. [87] on the detection of three full length mRNA transcripts (c-
myc, β-actin, and IL-8, in HL-60 cells) using microring resonators. The authors circumvented the 
problem of accessibility to target regions caused by mRNA structuring by employing chaperone 
DNA probes (small DNA helper strands complementary to the adjacent matching region) 
creating a localized duplex region with reduced secondary structures. To ensure specificity 
during detection, authors selected various capturing sequences for simultaneous use as 
receptors designed by BLAST searches (to target unique identifier regions of the primary 
sequence and successfully eliminate cross-hybridization among other mRNA species) and by 
Mfold prediction (to reduce the likelihood of secondary structures at the matching region). 
They also employed a two-step, bead-based, signal enhancement strategy to increase the 
sensitivity and to widen the linear range up to four orders of magnitude, reaching a detection 
limit of 512 amol (~2.5 pM). Finally, to fully demonstrate the capabilities of the biosensor array 
for mRNA analysis, Kindt et al. monitored the change in mRNA expression of the three 
transcripts upon differentiation of HL-60 cells. They detected changes in both myc and -actin 
mRNAs, but were unable to detect IL-8 mRNA transcripts due to their lower abundance. This 
result highlights the need for novel approaches offering greater sensitivity. 
A second example of mRNA detection by optical biosensors is a direct-detection 
strategy recently developed by Huertas et. al [88] using a portable SPR biosensor. The authors 
explored the analysis and quantification of the two main mRNA isoforms generated by 
alternative splicing of the pro-apoptotic gene Fas with no need of cDNA conversion and 
amplification steps, obtaining comparable levels of sensitivity than conventional qRT-PCR-
based methodology. In this study, to overcome accessibility problems due to the long length of 
the mRNA isoforms they performed a simple fragmentation step based on RNA alkaline 
hydrolysis prior detection. Cross-hybridization was reduced to background levels by 
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independently targeting the exon junction of each isoform and employing a highly stringent 
buffer based on formamide solution, strictly discriminating against the non-complementary 
isoforms (Fig. 4B). They achieved a limit of detection in the range of hundreds of picomolar 
(Fig. 4C) and demonstrated the validity of the methodology by using RNA samples from 
purified HeLa cell-extracts with different ratios and levels of expression of the two isoforms 
(Fig. 4D).  
Optical biosensors have also been employed for the detection of viruses, by the direct 
determination of their typically long single-stranded RNA (ssRNA). Griffin et al. [89] 
demonstrated for the first time that the non-linear optical (NLO) properties of gold 
nanoparticles (hyper-Rayleigh scattering) could be used for screening and quantifying HCV RNA 
without any modification, offering an excellent detection limit (80 pM) and selectivity (at the 
single base-pair mismatch level). 
 
 4.2.2. Triplex-forming RNAs and highly structured RNAs. Triplex-forming RNAs (TF-RNAs) and 
highly structured RNAs are typically long; and can be included in the category of long RNAs. 
Triplex-forming RNAs sequences contain a poly-purine or poly-pyrimidine motifs that can form 
a triple helix with a DNA duplex via Hoogsteen base-pairing rules [90]. These motifs are 
common in many coding and non-coding RNAs sequences [91] and, therefore, are interesting 
for RNA analysis. They enable RNA sequences to interact with genomic DNA or with proteins 
that bind triple-helices [90, 91]. 
Long, highly structured RNAs were explored by Carrascosa et al. [92] using a standard 
SPR sensor. They reported the label-free detection of a highly structured purified 96-mer RNA 
by exploiting that many ln-RNAs contain a triplex motif within their sequence (in this case a 12 
nt triplex motif) and could be therefore captured by duplex-receptor, with the subsequent 
formation of a triplex helix (see Fig. 5B). Their triplex-based strategy, which can be extended to 
detect TF-RNAs of any type, entailed the use of aminoadenine-modified tail-clamps, as 
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capturing duplex-probes. The main advantage incorporated by this new type of tail-clamps is 
that the duplex receptor largely enhances the stability of a given triplex, maximizing the 
chances for RNA target capture. With this method, they reported a detection limit of 200 pM 
(50 fmol) twice lower than with a conventional duplex approach. The most outstanding feature 
of this method is that it works better for long (e.g. mRNAs or lnc-RNAs) and structured RNA 
sequences than for short and less structured ones.  
The advantages of SPR sensors to monitor biomolecular interactions in real-time and 
label-free have also proven useful in the discovery of the mode of binding of potential TF-lnc-
RNAs, such as promoter-associated lnc-RNAs. These RNAs have demonstrated to bind DNA by 
triplex interaction and coordinate regulation of adjacent genes via epigenetics [9, 11]. 
Recently, SPR has been strategic for uncovering the binding mechanism of Particle, a lnc-RNA 
involved in regulation of the methionine adenosyltransferase (MAT2A) gene in response to 
low-dose radiation [9]. Experiments carried-out using conventional SPR demonstrated that 
Particle creates a triplex structure to regulate the expression of MAT2A via epigenetics.  
Structured RNAs have also been analyzed by Boucard et al. [93] using a SPR sensor. 
They employed a novel binding ligand, a bifunctional-binding aptamer, to simultaneously bind 
to the two stem−loop structures of the RNA target and reported affinity analyses of these 
interactions. Nair et al. [94] explored structured RNAs in a completely different way. They were 
interested on developing a model system for understanding RNA loop–loop interactions using 
SPR sensors. To address it they used the HIV TAR–TAR* (“kissing hairpin”) RNA complex and 
determined its formation kinetics. By immobilizing one of the hairpin loops (TAR*16) onto a 
streptavidin chip (by first biotinylating it at the 5´-end), they accurately determined the relative 
stabilities of two very tight RNA complexes (TAR–TAR* and TARs2U–TAR*) and they also 
investigated how divalent metal ions affect the RNA complexes.  
Finally, Mandir et al. analyzed the RNA-accessible sites of three pre-miRNAs (miRNA 
precursors of ~75 nt in length) by SPR (Fig. 6). They used an oligonucleotide array fabricated 
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with a thin layer of amorphous carbon deposited onto a SPR-active gold substrate [95]. With 
this approach, the group developed a single “universal array” that contains all possible 6-mer 
sequences that can bind to any accessible site of RNA molecules of any sequence in a rapid and 
label-free way. Identification of accessible sites for hybridization within the RNA sequence is an 
interesting approach for identifying antisense-mediated gene suppression sites. The rich 
secondary and tertiary structure adopted by RNA molecules leaves only a small portion of its 
sequence available for hybridization; therefore, those sites are considered to be strongly 
implicated in binding and regulation during RNA interference (RNAi).  
 
4.2.3. Ribosomal RNA. Ribosomal ribonucleic acid (rRNA) is the RNA component of the 
ribosome, the cell’s essential protein factory. Ribosomal RNAs comprise two subunits: a large 
subunit (LSU) and a small subunit (SSU). The molecular weight and genetic composition of the 
subunits differ among organisms, a feature that can be exploited to identify microorganisms. 
Since rRNA is present in a large amount within the cell, rapid ribosomal RNA analysis of the 
type of bacterial pathogens in clinical specimens is easy [96]. 
Two interesting manuscripts report on rRNA analysis using optical biosensors. In the 
first one, Joung et al. [97] used an SPR sensor and a peptide nucleic acid (PNA) as a capture 
probe for the detection of E. coli 16s rRNA. They employed a signal-enhancing method in 
which the 16s rRNA, once hybridized onto the PNA receptor layer, interacts with a cationic 
gold nanoparticle achieving a detection limit of  ~58 pg/mL (10 fM). 
Nelson et al. [98] used an SPR imaging array containing DNA probes (15 to 21 bases) 
designed to be complementary to 16S rRNA gene sequences of E. coli and B. subtilis as well as 
to a highly conserved sequence found in the rRNA of most bacteria. Using a standard 
commercial kit for RNA extraction, they were able to detect the RNA in less than 2 hours 
(including 1 hour for RNA hybridization). They achieved a detection limit of 2 µg/mL (3.8 nM) 
for fragmented E. coli in total cellular RNA. 
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5. Conclusions 
Optical biosensors have been garnering increasing attention due to their potential for rapid, 
direct and label-free analysis of RNA. Although not many examples of RNA detection have 
been reported to date, the methodology is applicable to a wide range of RNA types. Very 
interesting approaches have been developed for long RNAs in the monitoring of relevant 
biological situations, such as alternative splicing or in deciphering their biological mechanism 
of interaction with target DNA sequences. Promising approaches for the detection of 
structured RNA targets and small RNAs have also been devised. However, in most of the 
proposed strategies, detection of small RNAs at an adequate level of sensitivity required non-
target labeling amplification approaches. The principal objectives now facing researchers are 
the development of more accurate, sensitive and specific biofunctionalization methods, and 
the creation of more integrated and multiplexed platforms to allow simultaneous monitoring 
of numerous RNA targets with minimum sample pre-treatment, which should make the 
devices accessible to non-skilled users. 
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Box 1. Schematic of RNA types and functions 
Figure 1. Scheme of the working principle of a biosensor device 
Figure 2. Different types of optical biosensors. A) Scheme of a standard SPR biosensor and B) of an SPR 
imaging biosensor. C) Scheme of an integrated interferometer biosensor based on bimodal waveguides 
(BiMW): (a) Working principle showing the distribution of the electromagnetic field in the single mode 
and the bimodal sections; (b) envisioned lab-on-a-chip platform based on BiMW sensors; and (c) 
photograph of a chip (30 mm×10 mm) containing 16 BiMW interferometers. Reprinted with permission 
from The Royal Society of Chemistry (ref [52]) D) Photograph of a ring resonator biosensor. Reprinted 
with permission from ref [99] E) Photograph of a photonic crystal-based biosensor. Reprinted with 
permission from ref [75].   
Figure 3. Detection of small RNAs with optical biosensors. A) Scheme of the two-step assay developed 
by Sipova et al. for the detection of miRNA-122 with SPR.  Examples of the temporal sensor response to 
the miRNA-122 and its selective antibody, and the corresponding calibration curves, are included below. 
Reprinted with permission from ref [77] B) Schematic representation of the three-step assay developed 
by Fang et al. for the detection of miRNA 16, miRNA-122b and miRNA-23b with an SPR imaging 
platform. The monitoring of polyadenylation after capture of the miRNAs targets along with the 
calibration curves is also shown. Reprinted with permission from ref [56] C) Multiplexed detection of 
several miRNAs with the ring resonator based biosensor by Qavi et al. An example of the absolute 
wavelength shift after miRNA recognition and real-time evaluation of the selected miRNAs are shown. 
Reprinted with permission from ref [83](Copyright Wiley-VCH Verlag GmbH & Co. KGaA) 
 
Figure 4. SPR methodology for quantitative evaluation of Fas gene alternatively spliced mRNA isoforms. 
(A) Schematic representation of the different RNA and protein isoforms generated by alternative splicing 
of Fas gene/CD95. (B) Scheme for the label-free and direct detection of alternative spliced variants with 
an SPR biosensor. (C) SPR calibration plots for Fas57 (up) (R2= 0.99) and Fas56 (down) (R2=0.99) DNA-
probes using the optimized hybridization and detection conditions. (D) SPR analysis of different HeLa 
 29 
cells lineages presenting different expression levels of Fas isoforms for Fas56 DNA-probe. Reprinted with 
permission from ref [88]. 
Figure 5. Detection of TF-RNAs developed by Carrascosa et al. using an SPR biosensor. A) Triplex-
detection strategy using amino-modified tail-clamp receptors; and B) folding structure of the RNA 
target. C) Calibration curve of the detection of a purified RNA, and the two-folded enhanced signal 
obtained with the triplex strategy as compared to the duplex one. Reprinted with permission from Ref 
[92].  
Figure 6. Universal SPR imaging array developed by Mandir et al. comprising all possible 6-mer 
combinations for high throughput screening of RNA accessible sites. (A) SPRi difference image showing 
spots of hybridization for a solution 1 μM pre-let-7a3. (B) Histogram of the hybridization data obtained 
from the difference image. The y-axis corresponds to the average change in % reflectivity (Δ%R), and the 
x-axis corresponds to the location of the surface probe along the RNA sequence (Location 1 corresponds 
to nucleotides 1 through 6). The dotted horizontal line represents the cutoff line. Features with intensity 
changes greater than the cutoff line are considered accessible sites. (C) The lowest-energy structure of 
pre-let-7a3 predicted by Mfold. The red line indicates the 6-mer accessible sites determined from the 






























Modify ribosomal RNAs (rRNAs) by 
orchestrating the cleavage of the long 
pre-rRNA into its functional subunits 




200 nt to 
>100 Kb
200 nt to 
several Kb
Epigenetic regulators of transcription in 
cis/in trans
micro RNAs mi-RNAs 21-25 nt
Post-transcriptionally regulate mRNA 
stability and translation. It can also 
silence genes transcriptionally. 
Tiny RNAs ti-RNAs <22 nt
Regulate initiation of transcription and 
gene expression by controlling RNA 
polymerase II binding and behaviors, 
and modulating local epigenetic 
structure associated with transcription 




Guide modification of chromatin 
structure in the nucleus, thereby 
contributing to the establishment and 
maintenance of distinct chromatin 
domains.
200 nt to 
>100 Kb
They regul te protein expres ion by 
diverse mechanisms:                                           
        - As guides and tethers for 
chromatin-modifying complexes                                           
                            - As molecular scaffolds 
for protein complexes that lack 
protein–protein interaction domains                                             
                                     - By binding to 
transcription factors to preventing them 
from binding to their target DNA 
sequence                                           - By 
interacting directly with other ncRNAs 
(e.g. microRNAs) to prevent them from 
binding to mRNA.
TYPE SITE OF ACTIONFUNCTION
Coding
NAME
Encode the information for protein 
production; Represent ~2% of the 
genomic output





Non-coding                        

















DNA replication interference, chromatin 
remodeling, transcriptional regulation, 
RNA masking, double-stranded RNA 
(dsRNA) mediated siRNA mechanism 
and translation interference
Provide the machinery for protein 
synthesis from mRNA transcripts 
Nucleous or 
Cytoplasm
200 nt up to 
1 Mb



















Post-transcriptionally regulate mRNA 









influence gene and pseudogene 
expression, at both epigenetic and post-
transcriptional levels.
They regulate protein expression by 
diverse mechanisms:                                           
- As guides and tethers for 
chromatin-modifying complexes                                           
- As molecular scaffolds for protein 
complexes that lack protein–protein 
int racti n domains                                          
- By binding to transcription fac rs 
to preventing them from binding to 
their target DNA sequence                                           
- By interacting directly with other 
ncRNAs (e.g. microRNAs) to prevent 
them from binding to mRNA. 
Table 2 
RNA type Sample source Method Sensitivity Single/Multiplex detection Reference
Mouse liver total 
RNA
SPR 0.2 nM-2 pM Single Sipova et al . [77]
Synthetic RNA SPRi 40 nM-4 nM Single Nasheri et al.  [78]
Synthetic RNA SPRi 10 fM Multiplex Fang et al.  [56]
Mouse liver total 
RNA







50 pM Single Lee et al.  [80]
Synthetic RNA SPRi 100 fM Multiplex Zhou et al.  [81] 












2 nM Multiplex Qavi et al.  [83] 
Synthetic RNA SERS mM Multiplex Driskell et al.  [84]





160 pM Multiplex Kindt et al.  [87] 














SPR 200 pM Single Carrascosa et al.  [92]
SPR 10 fM Single Joung et al.  [97] 







E. Coli  extracted 
total RNA
